Arrowstreet Capital, Limited Partnership Sangamo Therapeutics, Inc Transaction History

Arrowstreet Capital, Limited Partnership

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $623,347 - $932,831	145,983 Added 1121.31%	159,002 $779,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $42,702 - $80,847	13,019 New	13,019 $54,000
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $1.07 Million - $1.68 Million	-98,603 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.23 - $18.18 $658,071 - $1.3 Million	-71,297 Reduced 41.96%	98,603 $1.54 Million
Q3 2020 Nov 12, 2020	BUY	$9.38 - $12.48 $931,724 - $1.24 Million	99,331 Added 140.76%	169,900 $1.61 Million
Q2 2020 Aug 12, 2020	SELL	$6.21 - $11.83 $7,644 - $14,562	-1,231 Reduced 1.71%	70,569 $632,000
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $362,590 - $635,430	71,800 New	71,800 $457,000
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $3.25 Million - $4.63 Million	-234,064 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$16.7 - $26.35 $3.91 Million - $6.17 Million	234,064 New	234,064 $4.45 Million

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.